marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
VYNE Therapeutics Cash Flow 2011-2024 | VYNE
Annual Cash Flow VYNE Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-25.3 M | -29.2 M | -56.4 M | -137 M | -73.4 M | -68.7 M | -28.2 M | -2.26 M | -4.18 M | - | - | - | - |
Depreciation & Amortization |
- | 72 K | 109 K | 341 K | 350 K | 319 K | - | - | - | - | - | - | - |
Accounts Payables |
1.66 M | 2.39 M | 6.51 M | 4.78 M | - | 3.29 M | 2.46 M | - | - | - | - | - | - |
Accounts Receivables |
- | - | 7.58 M | 15.8 M | - | - | 786 K | - | - | - | - | - | - |
Total Inventories |
- | - | - | 7.4 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow VYNE Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | - | -5.48 M | - | -25.3 M | -18.2 M | -9.04 M | - | -46.3 M | -28.8 M | -12.6 M | - | -112 M | -88.1 M | -52.2 M | - | -51.1 M | -29.4 M | -16.6 M | - | -36.1 M | -23.9 M | -11.2 M | - | -18.1 M | -5.55 M | -5.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | - | - | 227 K | 56 K | 44 K | - | 83 K | 55 K | 27 K | - | 254 K | 187 K | 93 K | - | 256 K | 163 K | 76 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
3.99 M | 4.52 M | 1.66 M | 716 K | 1.16 M | 2.21 M | 2.39 M | 2.52 M | 1.43 M | 3.61 M | 6.51 M | 7.62 M | 10.1 M | 3.49 M | 4.78 M | 4.78 M | 4.78 M | 4.78 M | 3.77 M | 2.99 M | 4.7 M | 3.78 M | 3.29 M | 3.29 M | 3.29 M | 3.29 M | 2.46 M | 2.46 M | 2.46 M | 2.46 M | 1.53 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | 250 K | 234 K | 105 K | 173 K | 471 K | 304 K | 535 K | 7.58 M | 10.1 M | 10.9 M | 10.8 M | 15.8 M | 15.8 M | 15.8 M | 15.8 M | 135 K | 135 K | 135 K | 135 K | - | - | 93 K | 234 K | 786 K | 786 K | 786 K | 786 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | 7.29 M | 8.07 M | 8.28 M | 8.09 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 1.36 M | 1.36 M | 1.36 M | 1.36 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency